Livzon Pharmaceutical Group Inc 2017 Annual Report with Sustainability Disclosures
Company: Livzon Pharmaceutical Group Inc
Sector: Manufacturing
Country: China
Year: 2017
Type: Annual Report with Sustainability Disclosures
Pages: 354
The report describes Livzon's 2017 disposal of Weixing, which was expected to generate RMB3,283,805,821.20 in unaudited accounting net profit for the Group. It also reports approximately RMB575.50 million in R&D expenditure and 6,963 current employees across the Company and its wholly-owned and controlling subsidiaries. A dedicated Social Responsibility section covers worker rights, safe production, environmental protection, and pollutant-management practices.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.